Active Biotech AB (publ) (STO:ACTI)
5.22
+0.12 (2.35%)
Jul 24, 2026, 5:18 PM CET
Active Biotech AB Employees
Active Biotech AB had 5 employees as of March 31, 2026. The number of employees did not change compared to the same quarter last year.
Employees
5
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-6.94M SEK
Market Cap
134.44M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 5 | 0 | - |
| Dec 31, 2025 | 5 | -1 | -16.67% |
| Sep 30, 2025 | 5 | -1 | -16.67% |
| Jun 30, 2025 | 5 | -3 | -37.50% |
| Mar 31, 2025 | 5 | -3 | -37.50% |
| Dec 31, 2024 | 6 | -2 | -25.00% |
| Sep 30, 2024 | 6 | -2 | -25.00% |
| Jun 30, 2024 | 8 | 0 | - |
| Mar 31, 2024 | 8 | 0 | - |
| Dec 31, 2023 | 8 | -1 | -11.11% |
| Sep 30, 2023 | 8 | -1 | -11.11% |
| Jun 30, 2023 | 8 | -1 | -11.11% |
| Mar 31, 2023 | 8 | -1 | -11.11% |
| Dec 31, 2022 | 9 | 1 | 12.50% |
| Sep 30, 2022 | 9 | 1 | 12.50% |
| Jun 30, 2022 | 9 | 1 | 12.50% |
| Mar 31, 2022 | 9 | 1 | 12.50% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Nanologica AB | 72 |
| Diamyd Medical AB | 44 |
| IRLAB Therapeutics AB | 31 |
| Biovica International AB | 25 |
| NextCell Pharma AB | 24 |
| Xintela AB | 11 |
| Alzinova AB | 7 |
| Simris Group AB (PUBL) | 5 |
Active Biotech AB News
- 2 months ago - Active Biotech AB Quarterly report: Q1 2026 - Filings
- 3 months ago - Active Biotech AB Slides: Company presentation - Filings
- 4 months ago - Active Biotech AB Slides: Company presentation - Filings
- 5 months ago - Active Biotech AB Annual report: Q4 2025 - Filings
- 5 months ago - Active Biotech AB Quarterly report: Q4 2025 - Filings
- 8 months ago - Active Biotech AB: Active Biotech's patent related to a pharmaceutical formulation of tasquinimod will be granted in the US - Finanz Nachrichten
- 9 months ago - Active Biotech AB Slides: Company Presentation - Filings
- 9 months ago - Active Biotech AB Quarterly report: Q3 2025 - Filings